1. Home
  2. TIVC vs INM Comparison

TIVC vs INM Comparison

Compare TIVC & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tivic Health Systems Inc.

TIVC

Tivic Health Systems Inc.

N/A

Current Price

$1.96

Market Cap

3.6M

Sector

Health Care

ML Signal

N/A

Logo InMed Pharmaceuticals Inc.

INM

InMed Pharmaceuticals Inc.

N/A

Current Price

$1.21

Market Cap

3.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TIVC
INM
Founded
2016
1981
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6M
3.7M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
TIVC
INM
Price
$1.96
$1.21
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
60.0K
762.3K
Earning Date
11-14-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$482,000.00
$4,798,116.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.47
$1.13
52 Week High
$15.64
$8.27

Technical Indicators

Market Signals
Indicator
TIVC
INM
Relative Strength Index (RSI) 44.24 38.05
Support Level $1.97 $1.16
Resistance Level $2.70 $1.48
Average True Range (ATR) 0.19 0.11
MACD 0.03 0.02
Stochastic Oscillator 19.39 13.89

Price Performance

Historical Comparison
TIVC
INM

About TIVC Tivic Health Systems Inc.

Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.

Share on Social Networks: